Vitenskapelig artikkel

• Randi Moe; Jan Erik Nordrehaug; Per Omvik et al. (1995). The Bergen blood pressure study. Prehypertensive changes in cardiac structure and function in offspring of hypertensive families. (ekstern lenke)
• Per Omvik; Eva Gerdts; Ole Langeland Myking et al. (1999). Similar central hemodynamics in salt sensitive and salt resistant hypertensive patients. (ekstern lenke)
• Eva Gerdts; Ole Langeland Myking; Per Lund-Johansen et al. (1997). Angiotensin converting enzyme inhibition and alpha<SUB>1</SUB>-receptor blockade as antihypertensive therapy in type-1 diabetic patients. (ekstern lenke)
• Per Lund-Johansen; I. Hjermann; Bjarne Magnus Iversen et al. (1993). Selective alpha%b-inhibitors: first- or second-line antihypertensive agents?. (ekstern lenke)
• Per R. Hildebrandt; Christian D. Tuxen; Sverre E. Kjeldsen et al. (2001). Er de nye antihypertensiva bedre end de gamle? Resultater fra hypertensions-studier (CAPPP, STOP-2, NORDIL, INSIGHT og ALLHAT) med nyere medikamenter. (ekstern lenke)
• Eva Gerdts; Per Lund-Johansen; Per Omvik (1998). Factors Influencing Left Ventricular Mass in Salt Sensitive and Salt Resistant Essential Hypertensive Patients. (ekstern lenke)
• Eva Gerdts; Gunnar Kvam; R Mo et al. (1998). The Bergen Blood pressure Study: changes in cardiac structure and function in offspring of hypertensive families. (ekstern lenke)
• Lennart Hansson; Thomas Hedner; Per Lund-Johansen et al. (2000). Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) STUDY. (ekstern lenke)
• Eva Gerdts; Ole Myking; Per Lund-Johansen et al. (1997). Factors influencing LVM in hypertensitive type-1 diabetic patients. (ekstern lenke)
• Eva Gerdts; Einar Svarstad; Sylvi Aanderud et al. (1998). Factors influencing reduction in blood pressure and left ventricular mass in hypertensive type-1 diabetic patients using captopril or doxazosin for months months. (ekstern lenke)
• Eva Gerdts; Per Lund-Johansen; Per Omvik (1998). Is salt sensitivity a temporary phenomenon?. (ekstern lenke)
• Lennart Hansson; Thomas Hedner; Per Lund-Johansen et al. (2000). Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study. (ekstern lenke)
• Per Lund-Johansen (2003). Intensive blood pressure treatment: beneficial for all but the smoking hypertensives?. (ekstern lenke)
• Sverre Erik Kjeldsen; Per Lund-Johansen (2016). Tynt grunnlag for å endre mål for blodtrykksbehandling. (ekstern lenke)
• Eva Gerdts; Ole Myking; Per Lund-Johansen et al. (1997). Factors influencing LVM in hypertensitive type-1 diabetic patients. (ekstern lenke)
• F Thorsen; L Ersland; H Nordli et al. (2003). Imaging of experimental rat gliomas using a clinical MR scanner. (ekstern lenke)
• Per Lund-Johansen (1999). Blood pressure and heart rate responses during physical stress in hypertension: modifications by drug treatment. (ekstern lenke)
• Bernd Timmermann; Rune Mo; Friederich C Luft et al. (1998). Beta-2 adrenoceptor genetic variation is associated with genetic predisposition to essential hypertension: The Bergen Blood Pressure Study. (ekstern lenke)
• Eva Gerdts; Einar Svarstad; Ole Langeland Myking et al. (1996). Salt sensitivity in hypertensive type-1 diabetes mellitus. (ekstern lenke)
• Eva Gerdts; Per Omvik; Per Lund-Johansen (1999). Reproducibility of salt sensitivity testing using a dictary approach in essential hypertension. (ekstern lenke)
• Eva Gerdts; Hans Bjørnstad; Richard B. Devereux et al. (2006). Exercise performance during losartan- or atenolol-based treatment in hypertensive patients with electrocardiographic left ventricular hypertrophy (a LIFE substudy). (ekstern lenke)
• Per Omvik; Eva Gerdts; Ole L. Myking et al. (2000). Long-term central hemodynamic effects at rest and during exercise of losartan in essential hypertension. (ekstern lenke)
• Per Lund-Johansen; Einar Stranden; Steinar Helberg et al. (2003). Quantification of leg oedema in postmenopausal hypertensive patients treated with lercanidipine or amlodipine. (ekstern lenke)
• Per Lund-Johansen; Roger S Kirby (2003). Effect of doxazosin GITS on blood pressure in hypertensive and normotensive patients: a review of hypertension and BPH studies. (ekstern lenke)
• Eva Gerdts; Ole Langeland Myking; Per Lund-Johansen et al. (1996). Factors influencing left ventricular mass in hypertensive type-1 diabetic patients. (ekstern lenke)
• Sverre E. Kjeldsen; Thomas Hedner; Jan Otto Syvertsen et al. (2002). Comparison of home and office blood pressure in treated hypertensives in the Nordic Diltiazem (NORDIL) Study. (ekstern lenke)
• Eva Gerdts; Einar Svarstad; Ole Landmark Myking et al. (1996). Salt sensitivity in hypertensive type-1 diabetes mellitus. (ekstern lenke)
• Lennart Hansson; Thomas Hedner; Per Lund-Johansen et al. (2000). Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) STUDY. (ekstern lenke)
• Per Omvik; Eva Gerdts; O Myking et al. (1999). Similar central hemodynamics in salt sensitive and salt resistant hypertensive patients. (ekstern lenke)
• Eva Gerdts; Einar Svarstad; Sylvi Aanderud et al. (1998). Factors influencing reduction in blood pressure and left ventricular mass in hypertensive type-1 diabetic patients using Captopril or Doxazosin for months. (ekstern lenke)
• Per Lund-Johansen (1998). Behandling av akutt hjerteinfarkt - trombolyse eller akutt PTCA?. (ekstern lenke)
• Per Omvik; Eva Gerdts; Ole Langeland Myking et al. (2000). Long-term central hemodynamic effects at rest and during exercise of losartan in essential hypertension. (ekstern lenke)
• Per Lund-Johansen; I. Hjermann; Bjarne Magnus Iversen et al. (1993). Alpha-receptor blockers - first- or second-line antihypertensive agents?. (ekstern lenke)
• Eva Gerdts; O. L. Myking; Per Lund-Johansen et al. (1997). Regression of left ventricular hypertrophy in type-1 diabetic patients using doxazosin as antihypertensive therapy @<abstract@>. (ekstern lenke)
• Eva Gerdts; E. Svarstad; Sylvi Aanderud et al. (1998). Factors influencing reduction in blood pressure and left ventricular mass in hypertensive type-1 diabetic patients using Captopril or Doxazosin for months. (ekstern lenke)

Konferanseforedrag

• Per Lund-Johansen (2002). Hemodynamics in hypertension. State of the art lecture. (ekstern lenke)
• Per Lund-Johansen (2002). Hjerteinfarkt. (ekstern lenke)
• Eva Gerdts; Per Lund-Johansen; Per Omvik (2000). The effect of losartan treatment on left ventricular hypertrophy in patients with essential hypertension. (ekstern lenke)
• Eva Gerdts; Einar Svarstad; Ole Langeland Myking et al. (1996). Salt sensitivity in hypertensive type-1 diabetes mellitus. (ekstern lenke)
• R. Mo; Per Omvik; Per Lund-Johansen (1997). The alerting reaction to conventional blood pressure measurement is more pronounced in offspring of hypertensive than normotensive parents. (ekstern lenke)
• Per Lund-Johansen (2002). Retningslinjer for blodtrykksbehandling. (ekstern lenke)
• Per Lund-Johansen (2002). Hemodynamic effects of antihypertensive drugs. (ekstern lenke)
• R. Mo; Per Omvik; Per Lund-Johansen (1997). Increased alerting reaction to conventional blood pressure measurement in offspring of hypertensive parents. (ekstern lenke)
• Eva Gerdts; Per Lund-Johansen; Per Omvik (2000). The effect of losartan treatment on left ventricular hypertrophy in patients with essential hypertension. (ekstern lenke)

Vitenskapelig bokkapittel

• Per Lund-Johansen (2000). Evolution of Hypertension and Hemodynamics. (ekstern lenke)
• Per Omvik; Per Lund-Johansen (2014). Hemodynamics and Hypertension. (ekstern lenke)
• Per Lund-Johansen (2004). Hemodynamic concepts of hypertension: cardiac output versus peripheral vascular resistance. (ekstern lenke)
• Per Lund-Johansen (1998). Hemodynamic Effects of Calcium Antagonists in Hypertension. (ekstern lenke)
• Per Lund-Johansen (2002). Hemodynamic effects of Calcium antagonists in hypertension. (ekstern lenke)
• Per Lund-Johansen (2000). Evolution of Hypertension and Hemodynamics. (ekstern lenke)

Vitenskapelig litteraturgjennomgang

• Per Omvik; Per Lund-Johansen (2009). Central haemodynamics of hypertension. (ekstern lenke)
• Sverre Erik Kjeldsen; Per Lund-Johansen; Peter M. Nilsson et al. (2016). Unattended blood pressure measurements in the systolic blood pressure intervention trial: Implications for entry and achieved blood pressure values compared with other trials. (ekstern lenke)

Leserbrev

• Per Lund-Johansen (2003). Røykekampanjen og virkeligheten. (ekstern lenke)
• Franz H. Messerli; Louis Hofstetter; Enrico Agabiti-Rosei et al. (2017). Reply. (ekstern lenke)

Fremhevet artikkel i media

• Per Lund-Johansen (1998). Hvem får trøbbel med hjertet?. (ekstern lenke)
• Per Omvik; Per Lund-Johansen (2004). Hvorfor ikke alltid diuretika?. (ekstern lenke)

Lederartikkel

• Franz H. Messerli; Louis Hofstetter; Enrico Agabiti-Rosei et al. (2017). Expertise: No longer a sine qua non for guideline authors?. (ekstern lenke)
• Franz H. Messerli; Louis Hofstetter; Enrico Agabiti-Rosei et al. (2017). Expertise: no longer a sine qua non for guideline authors?. (ekstern lenke)
• Per Lund-Johansen (2002). Blood pressure response during exercise as a prognostic factor. (ekstern lenke)

Doktorgradsavhandling

• Per Lund-Johansen (1968). Hemodynamics in early essential hypertension. (ekstern lenke)

Se en full oversikt over publikasjoner i Cristin